Order-of-magnitude gap: the company is already serving a demand source whose scale dwarfs its own current business
The model's full reasoning — Q4 2017 call → NOWe need to determine if management describes a mismatch of scale between the company and the demand it is already serving. The key is: the company is already inside a large flow of activity, and management explicitly contrasts its own size with that flow, treating the gap as central. Let's examine the transcript. Management talks about identity verification market, mobile deposit, etc. They mention "growing our ID revenue by 54%, and growing our SaaS transactions by more than 100%." They talk about the Equifax breach accelerating demand. They mention "we are beginning to see demand generated by the Equifax breach as enterprises look to Mitek to augment or replace traditional verification methods." They talk about "the global digital identity verification market" and "we believe identity verification will be a layered approach." They mention "we intend to use our balance sheet to grow both organically and through M&A." They acquired ICAR. But do they explicitly describe a mismatch of scale? They say "Mitek is redefining how citizens around the globe verify their identity in a digital world." They talk about "the ubiquity of mobile devices and cameras" and "the urgency to establish trust in digital commerce." They mention "Apple’s announcement of advanced 3-D face mapping" etc. They also talk about mobile deposit: "over 5900 financial institutions and over 80 million consumers using our mobile capture technology." That's a large installed base. But is that a mismatch? The company's revenue is $45 million. 80 million consumers is huge. But do they explicitly contrast? They say "Mitek pioneered mobile deposit and were committed to ongoing innovation." They talk about "the latest generation is the 23rd new release since Mitek invented mobile deposit 10 years ago." They mention "financial institutions love it even more because its one tenth the cost of processing a check inside the branch." They say "we are confident that we’ll see continued growth in mobile deposit in fiscal 2018 and for years to come." But they don't explicitly say "we have only captured a tiny fraction of the potential" or "the size of the market dwarfs our current revenue." They do say "consumer adoption over the past 12 months has continued to grow" and "there is still room for further growth." But that's not a specific mismatch.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| CRGO | Freightos Limited | Q1 2024 | 2024-05-20 | C+ |
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| TMCI | Treace Medical Concepts, Inc. | Q2 2022 | 2022-08-13 | B+ |
| GDRX | GoodRx Holdings, Inc. | Q2 2022 | 2022-08-08 | F |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| HROW | Harrow Health, Inc. | Q4 2021 | 2022-03-10 | C |
| RELY | Remitly Global, Inc. | Q4 2021 | 2022-03-02 | B |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| HSTM | HealthStream, Inc. | Q3 2017 | 2017-10-24 | C |
HROW · Q4 2021 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript shows management describing Harrow as already inside the large cataract surgery market (4.5–6 million procedures annually) with real, present-tense participation: thousands of customer relationships, shipping north of two million sterile ophthalmic units last year, and touching roughly one million cataract surgeries. They explicitly contrast this scale against 2021 revenues of $72.5 million, noting that even a modest share of the pass-through-eligible market (1 million procedures × premium pricing) would produce “a big number” and drive revenues “more than double” in the near term. They treat the current business as only the “earliest sliver” of what they are already positioned inside, with the binding question being how much of the existing flow they can capture rather than whether the flow exists. This meets both criteria. The answer is YES. The transcript shows management describing Harrow as already inside the large cataract surgery market (4.
WRBY · Q1 2024 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...YES The transcript explicitly states that the company is already inside the optical industry with real business (245 stores serving customers, 83% of stores offering exams, 2.36 million active customers, and growing revenue from glasses, contacts, and exams). Management then draws the size contrast directly, noting that even the longer 900-store target "would still represent a small fraction of the 45,000 optical shops in the U.S." and that over 50% of major metro areas have only one store.
HSTM · Q3 2017 → YESThe question is about whether management describes a MISMATCH OF SCALE between the company and the demand it is already serving. Specifically, the company is currently supplying something enormous rel...**YES** Management describes the company already being inside a much larger flow of activity (the 80 million-person healthcare workforce, of which 4.6 million are in post-acute settings) and explicitly treats the scale mismatch as the central point. They note their strong sales team is already a “steady contributor” to 4.